Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Immuneering Corp’s stock clocked out at $9.01, up 11.65% from its previous closing price of $8.07. In other words, the price has increased by $11.65 from its previous closing price. On the day, 0.53 million shares were traded. IMRX stock price reached its highest trading level at $9.05 during the session, while it also had its lowest trading level at $8.16.
Ratios:
To gain a deeper understanding of IMRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.70 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 02 ’25 when HAUSMAN DIANA bought 3,000 shares for $3.62 per share. The transaction valued at 10,874 led to the insider holds 3,000 shares of the business.
HAUSMAN DIANA bought 2,500 shares of IMRX for $8,989 on Jul 02 ’25. The Director now owns 2,500 shares after completing the transaction at $3.60 per share. On Jul 02 ’25, another insider, Neufeld Leah R, who serves as the CHIEF PEOPLE OFFICER of the company, bought 700 shares for $3.57 each. As a result, the insider paid 2,499 and bolstered with 10,729 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMRX now has a Market Capitalization of 374547712 and an Enterprise Value of 304878144.
Stock Price History:
The Beta on a monthly basis for IMRX is 0.47, which has changed by 1.8068535 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, IMRX has reached a high of $9.37, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of. The Stock is 84.99%, while the 200-Day Moving Average is calculated to be 241.93%.
Shares Statistics:
It appears that IMRX traded 1.19M shares on average per day over the past three months and 1055690 shares per day over the past ten days. A total of 35.99M shares are outstanding, with a floating share count of 29.82M. Insiders hold about 28.28% of the company’s shares, while institutions hold 9.21% stake in the company. Shares short for IMRX as of 1756425600 were 1830280 with a Short Ratio of 1.53, compared to 1753920000 on 1555893. Therefore, it implies a Short% of Shares Outstanding of 1830280 and a Short% of Float of 5.3600002.
Earnings Estimates
The current market rating for Immuneering Corp (IMRX) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.21 and low estimates of -$0.78.
Analysts are recommending an EPS of between -$1.29 and -$2.25 for the fiscal current year, implying an average EPS of -$1.65. EPS for the following year is -$1.63, with 5.0 analysts recommending between -$0.74 and -$2.15.
